ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,136,000 | +48.7% | 308,569 | +211.7% | 2.71% | +358.9% |
| Q1 2016 | $764,000 | -29.2% | 99,000 | -1.0% | 0.59% | -17.1% |
| Q4 2015 | $1,079,000 | +47.2% | 100,000 | -5.8% | 0.71% | +76.0% |
| Q3 2015 | $733,000 | +24.0% | 106,104 | +59.1% | 0.40% | -13.5% |
| Q2 2015 | $591,000 | -10.2% | 66,704 | 0.0% | 0.47% | -15.1% |
| Q1 2015 | $658,000 | +7.3% | 66,704 | +33.4% | 0.55% | -9.2% |
| Q4 2014 | $613,000 | – | 50,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
| RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
| ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
| RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
| DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
| Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
| SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
| Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |